Defining and Managing Expectations for Early Immunotherapy Cancer Trials

Publisher： Bentham Science Publishers

E-ISSN： 1876-1038|10|1|47-60

ISSN： 1574-8871

Source： Reviews on Recent Clinical Trials, Vol.10, Iss.1, 2015-05, pp. : 47-60

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Defining the role of aromatase inhibitors in the adjuvant endocrine treatment of early breast cancer

By Buzdar Aman   Chlebowski Rowan   Cuzick Jack   Duffy Sean   Forbes John   Jonat Walter   Ravdin Peter    

Current Medical Research and Opinion, Vol. 22, Iss. 8, 2006-08 ,pp. : 1575-1585

Informa Healthcare

Access to resources Recommend Favorite

Cancer immunotherapy

By Baxevanis Constantin N.   Perez Sonia A.   Papamichail Michael  

Critical Reviews in Clinical Laboratory Sciences, Vol. 46, Iss. 4, 2009-08 ,pp. : 167-189

Informa Healthcare

Access to resources Recommend Favorite

Clarifications and Expectations: Managing Barrier Integrity

By  

JCAH Perspectives, Vol. 32, Iss. 6, 2012-06 ,pp. : 3-5

Joint Commission Resources

Access to resources Recommend Favorite

Clarifications and Expectations: Managing Door Maintenance

By  

JCAH Perspectives, Vol. 32, Iss. 5, 2012-05 ,pp. : 6-8

Joint Commission Resources

Access to resources Recommend Favorite

Incidence of Non-AIDS-Defining Cancer in Antiretroviral Treatment-Naïve Subjects after Antiretroviral Treatment Initiation: An ACTG Longitudinal Linked Randomized Trials Analysis

By  

Oncology, Vol. 80, Iss. 1-2, 2011-05 ,pp. : 42-49

Karger

Access to resources Recommend Favorite